Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Moderna and Pfizer stocks rise amid new Covid variants
04:40pm, Monday, 21'st Aug 2023
Yahoo Finance Health Care reporter Anjalee Khemlani breaks down Covid vaccine maker stocks including Moderna (MRNA), Pfizer (PFE), and BioNTech (BNTX), rising as concerns grow about new Covid variants
Covid vaccine stocks jump as new variants emerge ahead of fall shot rollout
12:44pm, Monday, 21'st Aug 2023
Novavax, Moderna, Pfizer and its partner BioNTech are slated to roll out new shots designed to target the omicron subvariant XBB.1.5 this fall.
5 Safe Stocks Under $40 to Buy Immediately
11:28am, Monday, 21'st Aug 2023
This article is an excerpt from the InvestorPlace Digest newsletter. To get news like this delivered straight to your inbox, click here.
The 3 Most Undervalued Pharma Stocks to Buy Now: August 2023
05:30am, Monday, 21'st Aug 2023
There are sectors in the economy that go through an extended period of trending sideways to lower. A good example is the pharmaceutical sector.
7 Top Stock Opportunities on the Heels of the Latest Jobs Report
12:15pm, Sunday, 20'th Aug 2023
The latest jobs report showed a slowing pace of hiring which will affect stock market opportunities. The July jobs report showed slowing hiring with low unemployment.
The 3 Most Undervalued Dividend Stocks With Growth Potential to Buy Now: August 2023
07:00am, Sunday, 20'th Aug 2023
Investors could be undergoing a flight to safety to dividend stocks. The reasoning is simple.
3 Fantastic Stocks to Buy in a New Bull Market
06:54am, Sunday, 20'th Aug 2023
Eli Lilly has explosive growth potential. Novo Nordisk is worth its premium price tag.
New Covid vaccines from Pfizer, Moderna and Novavax will likely protect against Eris variant
10:33am, Friday, 18'th Aug 2023
The drugmakers designed their updated coronavirus shots to target the omicron subvariant XBB.1.5, which is slowly declining nationwide.
Covid booster jabs may go on sale in the UK for the first time
03:49am, Friday, 18'th Aug 2023
UK health officials have approved the private sale of Covid booster shots, marking a significant shift in approach to vaccine distribution. Previously, since the rollout began in December 2020, Covid
Pfizer's updated COVID shot effective against 'Eris' variant in mice study
02:57pm, Thursday, 17'th Aug 2023
Pfizer Inc said on Thursday its updated COVID-19 shot, which is being tested against emerging variants, showed neutralizing activity against the "Eris" subvariant in a study conducted on mice.
Pfizer Stock: The Right Time To Buy Now (Technical Analysis)
11:55am, Thursday, 17'th Aug 2023
Pfizer is facing significant revenue and earnings declines, primarily due to patent expirations of their leading drugs. Despite these challenges, Pfizer's resilience is highlighted by a robust dividen
Pharma stocks are typically shunned by Wall St. when people feel confident about economy: Jim Cramer
07:32pm, Wednesday, 16'th Aug 2023
'Mad Money' host Jim Cramer talks the Pharma industry facing off against the federal government over IRA provisions.
The 7 Most Undervalued Healthcare Stocks to Buy Now: August 2023
07:07pm, Wednesday, 16'th Aug 2023
Investors always hope to buy low and sell high. In order to do so, it's necessary to identify stocks that are undervalued.
Pfizer's (PFE) New Multiple Myeloma Drug Elrexfio Gets FDA Nod
11:00am, Wednesday, 16'th Aug 2023
The FDA's accelerated approval of Pfizer's (PFE) new multiple myeloma drug Elrexfio/elranatamab is based on data from the pivotal phase II MagnetisMM-3 study.
Pfizer (PFE) Seems Well-Poised for Long-Term Growth: Here's How
10:55am, Tuesday, 15'th Aug 2023
Though Pfizer's (PFE) revenues from COVID products are declining sharply, it is set to launch some key non-COVID products in 2023, which can drive long-term sales and profit growth.
